The Centers for Medicare & Medicaid Services this week held a Medicare Learning Network call on its new settlement option for health care providers with a low volume of appeals pending at the Office of Medicare Hearings and Appeals and Medicare Appeals Council. Announced last November, the settlement option began accepting expressions of interest Feb. 5 from eligible appellants with fewer than 500 Medicare Part A or Part B claim appeals combined as of Nov. 3, 2017, who may opt to settle appeals with total billed amounts of $9,000 or less in exchange for timely partial payment of 62% of the net Medicare approved amount. Participants must settle all eligible appeals. For more information, see the slides from the call. Interested providers may want to assess their eligibility for the settlement and the value for them of participating. CMS first announced the settlement option in its latest court filing in an ongoing lawsuit brought by the AHA and three hospitals to eliminate an appeals backlog at the administrative law judge level. The trial court is now evaluating the agency’s claim that it can’t meet the court-imposed targets for reducing the backlog.

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…